JNJ logo Johnson & Johnson +
Johnson & Johnson
+

Johnson & Johnson (JNJ) Business News

Track Johnson & Johnson in real time with a live news feed covering Johnson & Johnson stock news, official press releases, company announcements, and an archive of historical Johnson & Johnson news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
8:15 AM | Monday | Oct 12, 2026 24/7 Wall Street

Treasury Bills vs Dividend Stocks: Which Income Stream Actually Fits Your Retirement

NEW News Thumbnail
8:11 AM | Monday | Oct 12, 2026 Investopedia

Here's How Much Johnson & Johnson Stock Is Expected to Move After Earnings

NEW News Thumbnail
7:35 AM | Monday | Oct 12, 2026 24/7 Wall Street

Johnson & Johnson and UnitedHealth Report the Same Morning. Here's What Matters.

NEW News Thumbnail
8:52 PM | Sunday | Oct 11, 2026 Fool - Investing News

Which Pharmaceuticals ETF Is the Better Buy: iShares’ IHE or Invesco’s PJP?

News Thumbnail
5:46 PM | Sunday | Oct 11, 2026 Fool - Investing News

Which Healthcare ETF Is the Better Buy: Fidelity’s Broad FHLC or Invesco’s Biotech-Focused PBE?

News Thumbnail
2:37 PM | Sunday | Oct 11, 2026 247 Wallst

Could You Live on $6,750 a Month in Dividends? What It Takes, Without a Single Yield Trap

News Thumbnail
2:00 PM | Sunday | Oct 11, 2026 Barrons

Wells Fargo, Bank of America, Domino's, Johnson & Johnson, Inflation Data, and More to Watch This Week

News Thumbnail
2:58 AM | Sunday | Oct 11, 2026 Defense World

Johnson & Johnson (NYSE:JNJ) & Zentalis Pharmaceuticals (NASDAQ:ZNTL) Head-To-Head Contrast

News Thumbnail
2:58 AM | Sunday | Oct 11, 2026 Defense World

Johnson & Johnson (NYSE:JNJ) & Zentalis Pharmaceuticals (NASDAQ:ZNTL) Head-To-Head Contrast

News Thumbnail
11:56 AM | Friday | Oct 9, 2026 Zacks Investment Research

J&J Stock Ahead of Q3 Earnings: Should You Buy, Sell or Hold?

News Thumbnail
8:20 AM | Friday | Oct 9, 2026 24/7 Wall Street

4 Dividend Stocks Boomers Can Safely Buy Now and Hold Forever

News Thumbnail
8:00 AM | Friday | Oct 9, 2026 GuruFocus

New Johnson & Johnson ICOTYDE® (icotrokinra) long-term data demonstrate robust 2-year results in the treatment of adults and adolescents with plaque psoriasis

News Thumbnail
7:00 AM | Friday | Oct 9, 2026 PRNewsWire

New Johnson & Johnson ICOTYDE® (icotrokinra) long-term data demonstrate robust 2-year results in the treatment of adults and adolescents with plaque psoriasis

News Thumbnail
12:15 PM | Thursday | Oct 8, 2026 24/7 Wall Street

Big Yields Are Easy to Find. These 4 Dividend Stocks Have Something Better

News Thumbnail
10:16 AM | Thursday | Oct 8, 2026 Zacks Investment Research

Johnson & Johnson (JNJ) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

News Thumbnail
10:05 AM | Thursday | Oct 8, 2026 The Motley Fool

Prediction: Johnson & Johnson Will Be a Faster-Growing Company by 2030 Than Most Investors Expect

News Thumbnail
9:56 AM | Thursday | Oct 8, 2026 Zacks Investment Research

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

News Thumbnail
7:50 AM | Thursday | Oct 8, 2026 24/7 Wall Street

These 5 Dividend Stocks Are Americas Favorite Companies

News Thumbnail

Treasury Bills vs Dividend Stocks: Which Income Stream Actually Fits Your Retirement

24/7 Wall Street

8:15 AM | Monday | Oct 12, 2026

news photo
Loading...

Treasury bills guarantee your rate until maturity while Johnson and Johnson has raised its dividend for 64 straight years, but depending on your tax state and timeline, one of these income streams quietly keeps far more money in your pocket

Read full article redirect
8:15 AM | Monday | Oct 12, 2026

Treasury Bills vs Dividend Stocks: Which Income Stream Actually Fits Your Retirement

24/7 Wall Street

Treasury bills guarantee your rate until maturity while Johnson and Johnson has raised its dividend for 64 straight years, but depending on your tax state and timeline, one of these income streams quietly keeps far more money in your pocket

Read full article arrow
NEW News Thumbnail
8:11 AM | Monday | Oct 12, 2026

Here's How Much Johnson & Johnson Stock Is Expected to Move After Earnings

Investopedia

Johnson & Johnson is due to report earnings Tuesday morning, with traders expecting a move that could bring the stock closer to its recent record.

Read full article arrow
NEW News Thumbnail
7:35 AM | Monday | Oct 12, 2026

Johnson & Johnson and UnitedHealth Report the Same Morning. Here's What Matters.

24/7 Wall Street

Two healthcare giants drop their third-quarter numbers on the same morning, and what each reveals about drug costs, insurance margins, and guidance ranges will set the tone for the entire sector heading into 2027.

Read full article arrow
NEW News Thumbnail
8:52 PM | Sunday | Oct 11, 2026

Which Pharmaceuticals ETF Is the Better Buy: iShares’ IHE or Invesco’s PJP?

Fool - Investing News

Pharmaceutical stocks have been one of the best places to invest over the past year. Choosing between these two funds is really a question about how you want to own what comes next.

Read full article arrow
News Thumbnail
5:46 PM | Sunday | Oct 11, 2026

Which Healthcare ETF Is the Better Buy: Fidelity’s Broad FHLC or Invesco’s Biotech-Focused PBE?

Fool - Investing News

One offers broad diversification at 0.08% cost, while the other targets concentrated biotech growth with higher volatility.

Read full article arrow
News Thumbnail
2:37 PM | Sunday | Oct 11, 2026

Could You Live on $6,750 a Month in Dividends? What It Takes, Without a Single Yield Trap

247 Wallst

Six holdings, no yield traps, and a monthly income target that demands you bring serious capital to the table. The real question is whether each payout can actually hold up when occupancy slips, cash flow disappoints, or litigation lands.

Read full article arrow
News Thumbnail
2:00 PM | Sunday | Oct 11, 2026

Wells Fargo, Bank of America, Domino's, Johnson & Johnson, Inflation Data, and More to Watch This Week

Barrons

Big bank earnings arrive, with Citi, Goldman Sachs, JPMorgan Chase, and more reporting. Consumer and producer price indexes and existing home sales data will provide a read on the economy.

Read full article arrow
News Thumbnail
2:58 AM | Sunday | Oct 11, 2026

Johnson & Johnson (NYSE:JNJ) & Zentalis Pharmaceuticals (NASDAQ:ZNTL) Head-To-Head Contrast

Defense World

Zentalis Pharmaceuticals (NASDAQ: ZNTL - Get Free Report) and Johnson and Johnson (NYSE: JNJ - Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, risk, earnings, valuation and institutional ownership. Insider and Institutional Ownership 69.6% of Johnson

Read full article arrow
News Thumbnail
2:58 AM | Sunday | Oct 11, 2026

Johnson & Johnson (NYSE:JNJ) & Zentalis Pharmaceuticals (NASDAQ:ZNTL) Head-To-Head Contrast

Defense World

Zentalis Pharmaceuticals (NASDAQ: ZNTL - Get Free Report) and Johnson and Johnson (NYSE: JNJ - Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, risk, earnings, valuation and institutional ownership. Insider and Institutional Ownership 69.6% of Johnson

Read full article arrow
News Thumbnail
11:56 AM | Friday | Oct 9, 2026

J&J Stock Ahead of Q3 Earnings: Should You Buy, Sell or Hold?

Zacks Investment Research

JNJ heads into Q3 earnings with strong drug sales and new launches, but Stelara biosimilar competition and MedTech challenges could weigh on growth.

Read full article arrow
News Thumbnail
8:20 AM | Friday | Oct 9, 2026

4 Dividend Stocks Boomers Can Safely Buy Now and Hold Forever

24/7 Wall Street

Four Dividend Kings with streaks stretching back decades sit inside millions of retirement portfolios, but one of them is spending every dollar of free cash flow just to keep its streak alive.

Read full article arrow
News Thumbnail
8:00 AM | Friday | Oct 9, 2026

New Johnson & Johnson ICOTYDE® (icotrokinra) long-term data demonstrate robust 2-year results in the treatment of adults and adolescents with plaque psoriasis

GuruFocus

New Johnson and Johnson ICOTYDEÂ (icotrokinra) long-term data demonstrate robust 2-year results in the treatment of adults and adolescents with plaque psoriasisP

Read full article arrow
News Thumbnail
7:00 AM | Friday | Oct 9, 2026

New Johnson & Johnson ICOTYDE® (icotrokinra) long-term data demonstrate robust 2-year results in the treatment of adults and adolescents with plaque psoriasis

PRNewsWire

Phase 3 data presented at Fall Clinical Dermatology show high, sustained response rates in adults and adolescents, with nearly three-quarters achieving clear or almost clear skin at two years and a continued favorable safety profile SPRING HOUSE, Pa., Oct. 9, 2026 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced new two-year results from the Phase 3 ICONIC-LEADa study evaluating ICOTYDE® (icotrokinra), the first and only targeted oral peptide that precisely blocks the IL-23 receptor1, in adults and pediatric patients 12 years of age and older (adolescents) with moderate-to-severe plaque psoriasis.

Read full article arrow
News Thumbnail
12:15 PM | Thursday | Oct 8, 2026

Big Yields Are Easy to Find. These 4 Dividend Stocks Have Something Better

24/7 Wall Street

A fat yield can vanish overnight, but four dividend stocks on this list show you exactly where the cash comes from before you buy a single share.

Read full article arrow
News Thumbnail
10:16 AM | Thursday | Oct 8, 2026

Johnson & Johnson (JNJ) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

Zacks Investment Research

Besides Wall Street's top-and-bottom-line estimates for Johnson & Johnson (JNJ), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2026.

Read full article arrow
News Thumbnail
10:05 AM | Thursday | Oct 8, 2026

Prediction: Johnson & Johnson Will Be a Faster-Growing Company by 2030 Than Most Investors Expect

The Motley Fool

Johnson & Johnson's decision to separate from its consumer health segment could help raise top-line growth over the medium term. There are also important developments within the company's medtech division that could boost sales growth.

Read full article arrow
News Thumbnail
9:56 AM | Thursday | Oct 8, 2026

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks Investment Research

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Read full article arrow
News Thumbnail
7:50 AM | Thursday | Oct 8, 2026

These 5 Dividend Stocks Are Americas Favorite Companies

24/7 Wall Street

Procter and Gamble has raised its dividend every year for seven decades, and it is not even the highest-yielding name on this list. These five household giants reveal just how differently income investors can play the same dividend-safety game.

Read full article arrow
News Thumbnail